about
Felix d’Herelle and our microbial futureNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Bacteriophage Procurement for Therapeutic PurposesBacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrencePhage cocktails and the future of phage therapyBeyond phage therapy: virotherapy of protozoal diseasesTransient contacts on the exterior of the HK97 procapsid that are essential for capsid assembly.The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model.Compositional and functional features of the gastrointestinal microbiome and their effects on human health.In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.Complete Genome of Salmonella enterica Serovar Typhimurium T5-Like Siphophage StitchComplete Genome Sequence of Salmonella enterica Serovar Typhimurium Myophage MushroomFighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme.GP0.4 from bacteriophage T7: in silico characterisation of its structure and interaction with E. coli FtsZHigh Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in CyprusSmall Colony Variants and Single Nucleotide Variations in Pf1 Region of PB1 Phage-Resistant Pseudomonas aeruginosaAnalyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus)Inducible Prophage Mutant of Escherichia coli Can Lyse New Host and the Key Sites of Receptor Recognition Identification.Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineA Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosaNovel avenues for Clostridium difficile infection drug discovery.Use of encapsulated bacteriophages to enhance farm to fork food safety.Phage Therapy in the Era of Synthetic Biology.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.Binding domains of Bacillus anthracis phage endolysins recognize cell culture age-related features on the bacterial surface.Alterations in gp37 expand the host range of a T4-like phage.Tandem mass spectrometry determination of the putative structure of a heterogeneous mixture of Lipid As isolated from the lipopolysaccharide of the Gram-negative bacteria Aeromonas liquefaciens SJ-19a.Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection.Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.
P2860
Q22061776-CC36B2E7-A930-4678-ACCE-3D2C2FB21866Q24563742-618C672F-F35A-4C8E-961E-7B1F9A406056Q26738479-7C606177-9C8D-4D30-ADD8-3E4C07D94570Q26825752-57957289-3941-4DCE-B614-9A8A6B6929BDQ26995797-8FD5D909-E29B-4EBA-82E4-DE0AE0A0EA23Q29396924-8EFD788B-F1A2-4A94-91BE-8D85B1D9B283Q30360528-05FD9BBD-6D76-475A-ADA7-78BD13191DCEQ33652281-8188E14F-6795-4B30-A7ED-9400C282E720Q34274976-A9E824BA-FE68-450C-B990-94EADF029E4EQ34580667-EE11CA8F-527A-4AB3-9D57-C1DBE7D6784AQ35057267-D3F2994A-03AD-4564-92FA-091360CF2C0FQ35350119-542BBE9B-7340-466B-A27D-06893FA0A41EQ35871785-804195A8-4EAE-42C8-A9F6-BC96134653B1Q36076534-3C1CF245-D291-4E7C-B0FD-A2BE4EAD6358Q36456613-0057ED72-79E4-4E92-9A95-C0BAE98D54D3Q36665622-E02FAE9E-D126-473D-A8C8-2B2B100EDE64Q37173625-B9282AF7-C542-4713-A231-08153C813717Q37617370-2F71761A-9D9D-45A0-9F0B-9AEAF4A479E2Q37629864-B6E390AD-19FA-47BC-88D7-8C27B1B4AE9BQ37644025-7C6D21F0-0FFF-4E09-B6C6-05B208C7BF75Q37667229-D1209DBA-D64E-4936-BA20-62F54ACB6A90Q38083297-94E9C110-E9CF-4743-9527-2E062987021FQ38584325-8B49191D-E10C-417C-929F-54CAF21EDEC0Q38915649-72CB1267-8992-49A2-847E-93DE56EA4818Q39029801-4876DDA4-4056-44D7-BCAF-AAEA22A0DD34Q40890525-356CC573-8D62-4D8F-8F12-625E05EF7AEFQ41328677-E8626027-6408-4C77-A8A2-56D4C6287502Q47933873-74F5BC89-8234-4E44-8D3C-3FC31C7FB515Q53142349-E2FD6029-77A5-4047-A818-CC63C5761CECQ54950902-98AA8122-F182-477A-8548-5BD7AAD1709DQ55193419-EA5D20FB-CCC2-44D8-9E65-929751B7F036
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phage therapy: concept to cure
@ast
Phage therapy: concept to cure
@en
Phage therapy: concept to cure
@en-gb
Phage therapy: concept to cure
@nl
type
label
Phage therapy: concept to cure
@ast
Phage therapy: concept to cure
@en
Phage therapy: concept to cure
@en-gb
Phage therapy: concept to cure
@nl
altLabel
Phage Therapy: Concept to Cure
@en
prefLabel
Phage therapy: concept to cure
@ast
Phage therapy: concept to cure
@en
Phage therapy: concept to cure
@en-gb
Phage therapy: concept to cure
@nl
P2860
P3181
P356
P1476
Phage therapy: concept to cure
@en
P2093
Eric C Keen
P2860
P3181
P356
10.3389/FMICB.2012.00238
P407
P577
2012-01-01T00:00:00Z